Lost your password?

Blogs about: X International

Featured Blog

ProtAffin Biotechnologie, AG: Series B €4.0M

ProtAffin Biotechnologie (Austria) is focused on developing novel biotechnology therapeutic products for acute and chronic inflammatory diseases has closed a €4.0M Series A financing. Participants inc… more →

OnBioVC

ProtAffin Biotechnologie, AG: Series B €4.0M

arubenstein wrote 1 year ago: ProtAffin Biotechnologie (Austria) is focused on developing novel biotechnology therapeutic products … more →

Tags: XX - Inflammation, Series B

4-Antibody AG: Series A $18.5M

arubenstein wrote 2 years ago: 4-Antibody (Basel, Switzerland) a biopharmaceutical company developing optimal therapeutic antibody … more →

Tags: Series A, XX - Therapeutic Platform


Have your say. Start a blog.

See our free features →

Related Tags
All →

Follow this tag via RSS